Skip to content

Comparative Study of Baska & I-gel for Ventilation of Female Patients During Minor Procedures

Comparative Study of Baska & I-Gel for Spontaneously Ventilated Females During Minor Gynecological Procedures

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03140215
Enrollment
60
Registered
2017-05-04
Start date
2016-06-30
Completion date
2017-08-31
Last updated
2017-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medical Device Complication

Keywords

Baska, seal pressure, I-Gel, Supraglottic airway device

Brief summary

The study aimed to compare safety of the 3rd generation Supra-glottic airway device (SAD) Baska to the I-Gel , regarding seal pressure, fitting on the larynx (detected by Fiberoptic) & complications. The study will be done for females undergoing minor gynecological procedures under general anesthesia with spontaneous ventilation.

Detailed description

Population of study & disease condition : 2 equal groups (n=30), female patients enrolled for minor gynecological procedures (D&C or hysteroscopy), All patients received general anesthesia with spontaneous ventilation using Supra-glottic airway Device (SAD). Group A (Baska) & group B ( I-gel). Inclusion Criteria: Age: 18-55, American Society of Anesthesia (ASA) 1 or 2, BMI\<35 & Low risk of aspiration. Exclusion Criteria: Anticipated upper airway problem, Gastrointestinal tract (GIT, disease, pregnancy & High risk of aspiration. Methodology: All patients received fentanyl 1 micro gram/Kg, Propofol(2-4mg/Kg) was titrated to induce anesthesia, followed by manual ventilation with sevoflurane (2-4%) in Oxygen.All devices were inserted by one of 2 investigators. Data collection: 1- Demographic Data: age,weight,height.2-duration of anesthesia.3- Data related to device insertion: Time of insertion,duration of anesthesia, seal pressure,peak airway pressure, Fiberoptic (FO)view of the larynx ,vomiting or regurgitation, postoperative laryngeal spasm or blood on the device after removal. Primary outcome: To detect seal pressure and fitting against laryngeal aperture detected by FO. Secondary outcome:To determine Peak pressure, incidence of complications: vomiting or regurgitation, blood on the device after removal (indicating trauma to the airway) or postoperative laryngeal spasm.. Statistical analysis: For analysis of continuous variables independent sample t-test will be applied and for categorical variables chi-square test will be used.value of p\<0.05 will be considered significant. Sample size: Sample size was calculated using EpiCalc program using the following data : mean seal pressure for Baska :29.98 , mean seal pressure for I-Gel: 25.62. SD: 4.9 , study power 80% confidence interval . P value\<0.05. the calculated sample size was found to be 19 for each group (overall 38), so the investigators will allocate 30 patient in each group to avoid drop out. Statistical analysis: Source of funding This study will be attributed to Department of Anesthesiology, Faculty of medicine, Cairo University. Support will be provided solely from departmental sources. Keywords: Baska, I-Gel, Supra-glottic airway devices, seal pressure

Interventions

DEVICElaryngeal mask insertion (Baska)
DEVICElaryngeal mask insertion (I-gel )

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Female ASA1,2 * Age 18-55 * BMI\<35

Exclusion criteria

* Anticipated upper airway problem * GIT disease * Pregnancy * High risk of aspiration

Design outcomes

Primary

MeasureTime frameDescription
seal pressureseal pressure will be assessed 3minutes after induction of general anesthesia.Airway Sealing Pressure in cmH2O at 5 mins postplacement.The airway sealing pressure was the pressure at which leak starts. This leak pressure was calculated as the plateau airway pressure reached with fresh gas flow 6 l/min, and pressure adjustment valve set at 70 cmH2O..

Secondary

MeasureTime frameDescription
Fiberoptic view of the larynx.Fiberoptic view will be assessed 5 minutes after induction of anesthesia.The fiberoptic device will be introduced through the device to visualize & record the view
Peak airway pressure in CmH2Oduring the operation the operationThe peak airway pressure will be monitored during the operation time
incidence of vomiting and regurgitationfrom the start of operation till 10 minutes postoperativepatients will be monitored to detect vomiting & regurgitation.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026